4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-056884
Chief Executive Officer bought 1,000 shares at $4.08 ($4,080)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Plavan Matthew T Chief Executive Officer | 2019-11-14 | Purchase | +1,000 | $4.08 | $4,080 | 13,000 | D |
| Open-market purchases · 1,000 sh · avg $4.08 · $4,080 | |||||||
Loading xslF345X03/doc4.xml…